Epidemiology and Global Trend of Adenocarcinoma Professor Tony Mok Dept of Clinical Oncology The Chinese University of Hong Kong.

Slides:



Advertisements
Similar presentations
Treatment in Advanced Non-Small Cell Lung Cancer.
Advertisements

Global Epidemiologic Variability of EGFR Mutation NSCLC Keunchil Park, MD, PhD Professor Division of Hematology/Oncology Department of Medicine Sungkyunkwan.
Lung Cancer Causes Carcinogens, such as cigarettes Radiation Genetic susceptibility Viruses Wikipedia.org.
EGFR Mutation Testing From the Pathologist’s Point of View
1 Workplace E nvironmental T obacco S moke and Adenocarcinoma of the Lung Among N onsmoking M en Prof. TSE, Lap Ah Shelly 謝立亞 School of Public Health and.
Carcinoma Lung.
Lung Cancer. Lung Cancer Incidence 1950s Male/Female ratio 6:1, this is now 7:5. (decreasing male smoking rates, increasing female smoking rates). Approximately.
Risk factors of non-smoking lung cancer Po-Yin Chang.
Northern England Strategic Clinical Network Conference Thyroid Sub-group Update Dr Sath Nag Consultant Endocrinologist Vice Chair, Thyroid NSSG South Tees.
 Most frequently diagnosed cancer worldwide › About 1.35 million new cases diagnosed worldwide each year  Leading cause of cancer deaths in the United.
World Burden of Cancer Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.
Joint Hospital Surgical Grand Round 21 st July, 2012 RH.
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PANCREATIC CANCER RISK: A NESTED CASE-CONTROL STUDY Marie Bradley, Carmel Hughes, Marie Cantwell and Liam Murray.
Pulmonary Neoplasia Prof. Frank Carey. Lung Neoplasms r Primary l benign (rare) l malignant (very common) r Metastatic (Very common)
Medical aspects of asbestos exposure Sjaak Burgers respiratory physician Netherlands Cancer Institute, Amsterdam
Zuo-Feng Zhang, MD, PhD Epi242, Prospective:  Cohort Studies: Observational studies  Intervention Studies, Clinical Trials  Nested Case-Control.
GGAGATTCTGGGCCACTTTGGTTCCCCATGAGCCAAGACGGCACTTCTAATTTGCATTCCCTACCGGAGTCCCTGTCTGTAGCCAGCCTGGCTTTCAGCTGGTGCCCAAAGTGACAAATGTATCTGCAATGACAAAGGTACCC TGGAAGGGCTCGCCCTCTGCGGAATTTCAGTTCATGCAGGCCTTGGTGCTTCCACATCTGTCCAAGGGCCTTTCAAATGTGACTTTTAACTCTGTGGATTGATTTGCCCGG
Chapter 28 Lung Cancer. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Objectives  Describe the epidemiology of.
1.2 billion smokers globally 83% of global smokers (956 million) live in developing countries Prevalence rate (in 90s) MaleFemale Bangladesh4010 Turkey5926.
Slides last updated: October Relative contribution of risk factors to lung cancer burden 1. Alberg AJ & Samet JM, Epidemiology of Lung Cancer. Chest.
Slides last updated: October There are two main types of lung cancer 1 1.Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review,
 2011 Johns Hopkins Bloomberg School of Public Health Jonathan M. Samet, MD, MS Director, USC Institute for Global Health Professor and Flora L. Thornton.
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Measures of Association
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Lung Cancer Molecular Pathology of Cancer Boot Camp January 4, 2012 Jennifer Rider, ScD.
WORK UP & MANAGEMENT OF SOLITARY PULMONARY NODULE Seifu B Oct-04, 2007.
10/16/2015C.R. Apap1 Lung cancer: a preventable disease Epidemiology addresses issues related to   Heredity,  Life-style, and  Environment.
Figure S1. Quantile-quantile plot in –log10 scale for the individual studies The red line represents concordance of observed and expected values. The shaded.
Environmental Tobacco Smoke (ETS) and the Risk of Head and Neck Cancer: INHANCE Consortium Yuan-Chin Amy Lee Gene-Environmental Epidemiology Group International.
Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.
Literature searching & critical appraisal Chihaya Koriyama August 15, 2011 (Lecture 2)
Malignant tumor of the respiratory system Nasopharygeal carcinoma Lung cancer.
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Tim Wiemken PhD MPH CIC Assistant Professor Division of Infectious Diseases University of Louisville, Kentucky Confounding.
Groups of 100 diseases that develop across time. Characterized by uncontrolled cell division. Can develop in virtually any of the body’s tissues. Hereditary.
Chronic Obstructive Pulmonary Disease Steven Markowitz, Problem-Based Exercises for Environmental Epidemiology, Office of Global and Integrated Environmental.
Overall survival in NSCLC
Epidemiology 242: Cancer Epidemiology Zuo-Feng Zhang, MD, PhD Fall Quarter, 2009.
Sumitra Thongprasert, MD
LUNG CANCER!!! BY VICTORIA B 7F. Lung cancer is mainly caused by smoking cigarettes. There are other causes though but the most common is smoking. Lung.
Slides last updated: March There are two main types of lung cancer 1 1.Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review,
Clinicopathologic Features of EML4-ALK Mutant Lung Cancer Shaw AT et al. ASCO 2009; Abstract (Poster)
Cancer of the Head and Neck and HPV Infection Andrew Urquhart MD, FACS Dept. Otolaryngology/Head and Neck Surgery Marshfield Clinic.
Personalized medicine in lung cancer R4 김승민. Personalized Medicine in Lung Cancer patients with specific types and stages of cancer should be treated.
Smoking in England Robert West Jamie Brown University College London 1.
Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,
Annals of Oncology 23: 298–304, 2012 종양혈액내과 R4 김태영 / prof. 김시영.
Cell Biology & Cancer Unit Objective 1 Cancer types, incidence, pre-disposition, and risk factors Biomedical Technology.
Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
EXPOSURE TO TOBACCO SMOKE IN THE EUROPEAN UNION 2nd Working Meeting on Adult Premature Mortality in the European Union October 2006, Warsaw, Poland.
Lung Cancer incidence in Māori – increased susceptibility mediated through COPD. Dr Rob Young BMedSc, MBChB, DPhil (Oxon) FRACP, FRCP Associate Professor.
EPIDEMIOLOGY AND AETIOLOGY OF LUNG CANCER
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
The smoking epidemic and lung cancer in the EU
TOBACCO AND UROGENITAL CANCER
Biomedical Technology
Cell Biology and Cancer Unit H.
폐암검진, 누구에게 필요한가? 분당서울대병원 내과 윤 호일.
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Cancer of the Head and Neck and HPV Infection
Meta-analysis of randomised phase III clinical trials comparing EGFR tyrosine kinase inhibitor (TKI) shows that male patients with non-small cell lung.
Meta-analysis of randomised phase III clinical trials with ALK inhibitors in non-small cell lung cancer (NSCLC) showing similar benefit in male patients.
Final Overall Survival Results from a Phase III, Randomized, Placebo-Controlled, Parallel-Group Study of Gefitinib Versus Placebo as Maintenance Therapy.
Biomedical Technology
Lung cancer incidence rates in young women versus young men: A systematic analysis in 40 countries Miranda fidler-benaoudia, Lindsey torre, Freddie bray,
Trends in survival from metastatic lung cancer in California,
Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.
Prepared by staff in Prevention and Cancer Control.
Presentation transcript:

Epidemiology and Global Trend of Adenocarcinoma Professor Tony Mok Dept of Clinical Oncology The Chinese University of Hong Kong

Rising incidence in adenocarcinoma?

Age Adjusted Incidence Rate of Adenocarcinoma in USA (per 100,000) Wu JNCI 1986, Dodds JNCI 1986, Travis Cancer 1995 More so in patients<65 year old

Age Adjusted Incidence Rate of Squamous Cell Carcinoma in USA (per 100,000) Wu JNCI 1986, Dodds JNCI 1986, Travis Cancer 1995

Change in ratio of adenocarcinoma vs SCC

Change in Percentage of Adenocarcinoma Subtype in Asia Japan Hong Kong

Change in Percentage of Squamous Cell Carcinoma Subtype in Asia Japan Hong Kong

Percentage of Adenocarcinoma in Female European (80’)

A global trend towards an increase in both the total number and proportion of adenocarcinoma. WHY?

Adenocarcinoma in smoker

Cigarette Filters Invented in 1935 Popularized in the 60’ In the 50’, filters were manufactured from crocidolite asbestosis. Banned since the association with lung cancer and mesothelioma Now made from acetalated cellulose Claims to reduce larger particles including tars and nicotine

Cancer Cell Type and Lung Airway Compartments Modified from Sun, Schiller, and Gazdar, Nat Rev Cancer, 7:778, 2007 Squamous Ca SCLC Adenocarcinoma © 2007 Nature Publishing Group Less large particle may Imply less exposure of Carcinogen in larger airways Less large particle may Imply less exposure of Carcinogen in larger airways

Filtered cigarette in USA Market 95%

Smoking-Related Lung Cancer Cell Type (Male) Morabia A Cancer 68:2074, 1991

Smoking-Related Lung Cancer Cell Type (Female) At a history of 40 pack-years relative to lifelong nonsmoking, the odds ratio for women was 27.9 (95% confidence interval (CI) ) and that for men was 9.60 (95% CI ). Morabia A Cancer 68:2074, 1991

Increase in tobacco consumption with filtered cigarette At a history of 40 pack-years relative to lifelong nonsmoking, the odds ratio for women was 27.9 (95% confidence interval (CI) ) and that for men was 9.60 (95% CI ). Higher consumption of tobacco in female who switched from non-filtered to filtered cigarette. Risch H Am J Epidermiol 138:281, 1993

Changes in nature of cigarette High nitrate content –Enhances combustion –Increase N-nitrosamines Favor –Impact of combusted flavorants is unknown Larger puffs with low-yield cigarettes –Inhale more deeply –Puff volume at 55ml at 5 times per minutes

Summary on smoking-related adenocarcinoma A trend toward increase in adenocarcinoma of lung in smoker Cigarette filter and modified tobacco contributed to the higher incidence –Exposure of carcinogens to lower airway –Deeper and larger puffs

Adenocarcinoma in non-smoker

Lung Cancer in Never Smokers Squamous Cell Ca (~35%) Adenocarcinoma (~45%) Predominance of Adenocarcinoma Histology SCLC (~20%) Percentage Smokers (n = 21,853) Never Smokers (n = 5,144) Adenocarcinoma Squamous Cell Ca Modified from Sun, Schiller and Gazdar, Nat Rev Cancer, 7:778, :13.4:1

Change in cigarette consumption in USA Rise in incidence of adenocarcinoma despite the decline in tobacco consumption

Adenocarcinoma in non-smoker USA –Rising incidence in non-smoker but histologic subtype were not available –Detection bias not clear from older studies Asia –Denial of smoking history in female population –Only two small studies suggested a rise in incidence of adenocarcinoma Wu JNCI 74:747, 1985; Kabat G Cancer 755, 1984; Koo Int J Epidermiol S14, 1990 SmokerNon-smoker Male (USA)25-33%31-54% Female (USA)33-43%49-73% Female (Asia)29%64-80%

Impact of rising incidence of adenocarcinoma in China: 2000–2005 No. of new cases% of change Age-standardised mortality rates (per 100,000) Male261,839332, Female119,648165, % non-smoker Yang et al Can Epi Bio Prv 14(1):243<2005 Parkin et al CA Cancer 55:74, 2005

Lung Cancer not related to smoking in China 25% of male lung cancer were not smoking related 72% of female lung cancer were not smoking related Wang et al Cancer Causes and Control 21:959, 2010

Majority of lung cancer in non-smokers are adenocarcinoma and total number of lung cancer is increasing, but there is no definite evidence of increase in proportion of adenocarcinoma

Carcinogenesis of adenocarcinoma in non-smoker: Atypical adenomatous hyperplasia (AAH) Modified from Gazdar et al, in press Lancet Oncology 2009 AAH in 23-35% of adenocarcinomas vs. 3-7% of squamous cell ca (Nakanishi et al Br J Cancer, 1990; Chapman et al, Br J Cancer, 2000) BAC Adenocarcinoma Atypical Adenomatous Hyperplasia (AAH)

Lung Cancer in Never Smokers Different Molecular Pathways TP53 (n=137) KRAS (n=846) Mutations 1 Percentage Smokers Non Smokers 71% 48% 21% 4% 1 Modified from Sun et al, Nat Rev 7:778, Modified from Riely et al, Clin Cancer Res 14:5731, G-T and A-G at CpG sites G-A Transition Percentage TP53 Mutations (n=137) G-A Transition G-T / G-C Transversion Percentage KRAS Mutations (n=482) 2

EGFR versus KRAS Driven Lung Cancer Sun et al Nat Rev Cancer, 7:778, 2007 Never Smoker EGFR Signaling Pathway Smoker KRAS Signaling Pathway

Oncogene in Chinese Patients with NSCLC An SJ,…Wu YL Plos ONE 7(6):e40109

Genome profile of smoker vs non- smoker adenocarcinoma in China

Meta-analysis of Risk Factors in Never Smokers Risk FactorRisk (Hazard Ratio with 95% CI) Meta-analysis Cooking Fume2.12 (1.81 to 2.47)7 studies from China/Taiwan Environmental Tobacco Smoking 1.21 ( )44 case-control studies Coal burning2.66 (1.39 to 5.07)7 studies from China/Taiwan Family History1.51 (1.11 to 2.06)28 case control studies Report of US Surgeon General 2006, Zhao Total Environ 366:500, 2006 Matakidou et al Br J Can 93:825, 2006 What is the genetic factor that predispose non-smokers to develop adenocarcinoma of lung??

What are other potential explanations for change in incidence of adenocarcinoma in non-smoker?

Change in Environmental Tobacco Smoking Increase in tobacco consumption from 60’ to 80’ may indirectly increase spousal exposure to environmental tobacco smoking Non-smoking female spouse of male smoker had about 30% increase in risk of lung cancer (OR 1.30) No difference between adenocarcinoma (OR 1.29) and non-adenocarcinoma (OR 1.37) Fontham JAMA 271:1752, 1997

Change in classification and pathological technique Charloux et al Int J Epidemiology 26:14, 1997

Change in diagnostic procedure Adenocarcinoma is previously under-diagnosis –43 of 153 lung cancer only diagnosed post mortem (30% in non-smoker vs 8% in smoker) Advances in fibro-optic bronchoscopy and needle aspiration –53-75% of adenocarcinoma present a peripheral nodule, and routine needle biopsy started only in Rigid Bronchoscopy SurgeryAutopsy Adenocarcinoma2%10%28% Squamous cell carcinoma 42%54%35% Theros AM Roentgen 128:893, 1983; Whitewell BJC 15:440, 1961

Summary Global trend in increase in incidence of adenocarcinoma Increase in adenocarcinoma in smokers –Cigarette filter and higher consumption contribute to the increase Increase in adenocarcinoma in non-smokers –Major of non-smoker lung cancer is adenocarcinoma but no definite evidence on rising proportion –Etiology and carcinogenesis of adenocarcinoma involve distinguish molecular change –Environmental factors contribute the increase but real reason is not known –Diagnostic bias exists